Verify patient identity and confirmed diagnosis. Confirm patient weight and current medication list to rule out contraindications (e.g., systemic fungal infections, ocular herpes simplex). Assess baseline blood pressure and fluid status. Ensure informed consent is obtained and the medication has been allowed to reach room temperature.
Observe the patient for 15–30 minutes post-injection for signs of allergic reaction or systemic intolerance. Provide education on common side effects such as injection site irritation or mood changes. Instruct the patient to contact the clinic if they experience symptoms of infection, severe edema, or persistent hypertension. Discharge immediately once stable.
Comprehensive Clinical Guide: Acthar Gel (Repository Corticotropin Injection) Administration
1. Introduction & Overview
Acthar Gel (Repository Corticotropin Injection) is a highly specialized, potent therapeutic agent derived from porcine pituitary glands. Unlike synthetic corticosteroids that act directly on glucocorticoid receptors, Acthar Gel acts as an adrenocorticotropic hormone (ACTH) analog. It stimulates the adrenal cortex to produce endogenous cortisol, corticosterone, and aldosterone. This mechanism provides a complex, multifaceted physiological response that differs significantly from exogenous corticosteroid administration.
This guide serves as a rigorous clinical reference for healthcare providers, nursing staff, and medical administrators involved in the prescription, preparation, and administration of Acthar Gel. Given its potent systemic effects, strict adherence to established protocols is mandatory to ensure patient safety and therapeutic efficacy.
2. Technical Specifications & Mechanism of Action
Acthar Gel is a long-acting formulation of corticotropin. It is designed for intramuscular (IM) or subcutaneous (SC) administration.
The Melanocortin Pathway
Acthar Gel exerts its effects by binding to melanocortin receptors (MCRs), specifically MC1R through MC5R, located on the surface of adrenal cells and various peripheral tissues.
* Adrenal Stimulation: Binding to the MC2R receptor on the adrenal cortex triggers the cAMP signaling pathway, leading to the rapid synthesis and release of endogenous cortisol.
* Extra-adrenal Effects: Emerging clinical evidence suggests that Acthar Gel may exert anti-inflammatory and immunomodulatory effects independent of adrenal stimulation via direct interaction with melanocortin receptors on macrophages, T-cells, and B-cells.
Pharmacokinetics
- Onset: Typically within 1 to 2 hours post-injection.
- Duration: The "repository" nature of the gel allows for sustained release, with therapeutic effects often lasting up to 72 hours.
- Metabolism: Hepatic metabolism with renal excretion of metabolites.
3. Clinical Indications & Usage
Acthar Gel is indicated for a wide range of conditions, primarily those involving chronic inflammation or autoimmune dysfunction.
| Condition Category | Specific Indications |
|---|---|
| Neurological | Infantile Spasms (IS), Multiple Sclerosis (MS) exacerbations |
| Rheumatologic | Psoriatic arthritis, Rheumatoid arthritis, Ankylosing spondylitis |
| Dermatologic | Severe erythema multiforme, Stevens-Johnson syndrome |
| Ophthalmic | Severe acute/chronic allergic/inflammatory processes |
| Respiratory | Symptomatic sarcoidosis |
| Connective Tissue | Systemic Lupus Erythematosus (SLE), Dermatomyositis |
Usage Protocol Summary
- Infantile Spasms: Typically administered via IM injection at a dose of 150 U/m² per day, divided into twice-daily injections.
- MS Exacerbations: Generally 80–120 units daily for 2–3 weeks.
- Rheumatic/Autoimmune: Dosing is highly individualized based on disease severity and patient response.
4. Patient Preparation & Administration Procedure
Pre-Administration Checklist
- Baseline Diagnostics: Complete Blood Count (CBC), electrolyte panel (specifically potassium), fasting glucose, and blood pressure monitoring.
- Infection Screening: Assess for active systemic infections (fungal, bacterial, or viral). Acthar Gel is contraindicated in patients with systemic infections.
- Vaccination Status: Review status; live vaccines are contraindicated during therapy.
- Patient Education: Ensure the patient/caregiver understands the injection technique, as many patients transition to home-based administration.
Step-by-Step Administration Guide
- Preparation: Remove the vial from the refrigerator and allow it to reach room temperature (approx. 15–30 minutes). Do not shake vigorously; roll the vial gently between palms.
- Site Selection:
- IM: Deltoid, vastus lateralis, or ventrogluteal site.
- SC: Abdominal fat (avoiding the umbilicus), outer thigh, or back of the arm.
- Injection Technique:
- Cleanse the site with alcohol.
- For IM: Insert needle at 90 degrees. Aspirate briefly to ensure no vessel penetration.
- For SC: Pinch skin and insert needle at 45–90 degrees.
- Inject slowly to minimize discomfort.
- Post-Injection: Apply gentle pressure with gauze. Do not massage the site.
5. Post-Op Recovery & Monitoring Protocol
Because Acthar Gel triggers endogenous cortisol production, patients must be monitored for signs of hypercortisolism (Cushingoid features) and metabolic disturbances.
Monitoring Schedule
- Weekly: Blood pressure, serum glucose, and serum potassium levels.
- Monthly: Symptom assessment for edema, mood changes, and weight gain.
- Long-Term: Bone mineral density (BMD) scans if therapy exceeds 3 months, as secondary osteoporosis is a risk.
6. Risks, Side Effects, and Contraindications
Major Contraindications
- Systemic fungal infections.
- Ocular herpes simplex.
- Recent surgery.
- Congestive heart failure (CHF) or uncontrolled hypertension.
- Psychosis.
Adverse Effect Profile
- Common: Fluid retention, hypertension, increased appetite, weight gain, insomnia.
- Serious: Increased infection risk, peptic ulcer disease, electrolyte imbalance (hypokalemia), psychiatric disturbances (depression, mania), and adrenal insufficiency upon sudden withdrawal.
7. Alternative Treatments
When Acthar Gel is contraindicated or ineffective, clinicians often pivot to:
1. Synthetic Glucocorticoids: Prednisone, Methylprednisolone (faster acting but lack the melanocortin-specific receptor modulation).
2. Biologic DMARDs: TNF-alpha inhibitors (e.g., Adalimumab) for rheumatologic conditions.
3. Intravenous Immunoglobulin (IVIG): Often used in neurological autoimmune conditions.
4. Plasmapheresis: Used in severe MS exacerbations where pharmacological agents fail.
8. Frequently Asked Questions (FAQ)
1. Why is Acthar Gel different from Prednisone?
Prednisone is an exogenous steroid. Acthar Gel stimulates your own adrenal glands to produce natural cortisol and other steroids, which may offer a different side effect profile and therapeutic mechanism.
2. Can I store Acthar Gel at room temperature?
No. Acthar Gel must be stored in the refrigerator (2°C to 8°C). If it is accidentally left out, consult your pharmacist before use.
3. What should I do if I miss a dose?
Administer the dose as soon as you remember. If it is nearly time for the next dose, skip the missed one. Do not double the dose.
4. Why is my potassium monitored during therapy?
Acthar Gel can cause the body to excrete potassium, leading to hypokalemia, which can cause muscle weakness and heart rhythm irregularities.
5. Will I experience "withdrawal" symptoms?
Yes. If used for a prolonged period, the dose must be tapered to allow the adrenal glands to resume normal function. Sudden cessation can lead to adrenal crisis.
6. Can I receive live vaccines while on Acthar?
No. Acthar is an immunosuppressant; live vaccines may cause uncontrolled infection.
7. Does Acthar Gel cause weight gain?
Yes, fluid retention and increased appetite are common side effects that can lead to weight gain.
8. Is the injection painful?
Some patients report discomfort due to the viscosity of the gel. Using a smaller gauge needle and ensuring the medication is at room temperature can help.
9. Can I drive after the injection?
Acthar Gel does not typically cause impairment, but if you experience dizziness or severe mood changes, avoid driving.
10. How long does it take to see results?
In acute MS flares, some patients feel improvement within 48–72 hours, though full therapeutic benefit may take longer depending on the condition being treated.
9. Conclusion
Acthar Gel (Repository Corticotropin Injection) remains a vital tool in the rheumatological and neurological armamentarium. Its ability to stimulate the endogenous corticosteroid pathway provides a unique therapeutic modality that remains unmatched by synthetic alternatives in specific patient populations. However, its administration requires a high degree of clinical vigilance, particularly regarding electrolyte management, infection monitoring, and the necessity of a structured tapering regimen upon discontinuation. Healthcare providers must ensure that patients are thoroughly educated on the signs of adrenal insufficiency and the critical importance of treatment adherence.
Disclaimer: This document is for educational purposes for healthcare professionals and does not replace the official FDA-approved prescribing information. Always consult the latest manufacturer package insert and institutional protocols before clinical administration.